Pure Nickel Inc

Birch Hill Equity Partners Management Inc. is a Canadian mid-market private equity firm based in Toronto, managing over $6 billion in capital. Since its inception in 1994, Birch Hill has made 73 investments, with a strong focus on driving growth in its portfolio companies across diverse industries in Canada and the United States. With a proven track record, Birch Hill has achieved an 18% cumulative average rate of EBITDA growth on actively employed capital and emphasizes data-driven decision-making to enhance value for its partner companies. Today, its 14 partner companies collectively generate over $8 billion in total revenue, employing more than 40,000 individuals. Generated from the website

Marathon Mortgage Corp is a Canadian mortgage lender based in Toronto, ON, specializing in partnering with mortgage brokers to provide tailored lending solutions. With a focus on personalized service, they offer a diverse range of mortgage products designed to meet the unique needs of borrowers, whether first-time homebuyers or those looking to refinance or invest. Committed to simplifying the mortgage process, Marathon Mortgage Corp collaborates closely with brokers to ensure clients receive competitive rates and smart financing options. They aim to empower individuals with their mortgage choices, guiding them toward informed financial decisions amidst the ever-evolving mortgage landscape. Generated from the website

DRI Capital Inc, based in Toronto, ON, is a pioneer in Pharmaceutical Royalty Monetization. Specializing in building a diversified portfolio of interests in medicines, the company focuses on products that effectively treat and address unmet medical needs. With tailored offerings, DRI Capital Inc serves as a best-in-class partner for investors and innovators. The company prides itself on multiple repeat deal partners and offers unique, creative, and flexible structures to meet the needs of its counterparts. As a smart capital allocator, DRI Capital Inc acquires dependable, patent-protected cash flow streams from the sales of significant drugs across various therapeutic areas. By actively sourcing royalty streams on medically necessary products with long-term patent protection and high growth potential, the company drives value creation for its portfolio and investors. Generated from the website content